We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Incubation Period for Mad Cow Disease May Be 60 Years

By Biotechdaily staff writers
Posted on 07 Jul 2006
Print article
New findings show that the incubation period for variant Creutzfeldt-Jakob (vCJD) disease in humans, the human form of mad cow disease, may be much longer than supposed, perhaps as long as 60 years or more.

Researchers from the University College of London (UCL, UK) identified a prion disease called kuru among the people of New Guinea that occurred mainly in women and children who took part in funeral feasts that included the brains of relatives. Boys older than eight customarily did not take part in these feasts.

The researchers took histories of residence and participation in funereal feasts and combined the information with data from serial neurologic examinations, when available. In all, they identified 11 patients, seven man and four women, with kuru. All of them were born before the practice of including brains in the funeral feasts was stopped in the 1950s. The researchers used experimental, epidemiologic, and human behavioral evidence to conclude that the practice had definitely stopped by 1960.

"Therefore, we could define the minimum incubation period as the time between 1960 and the date of onset of kuru,” wrote the researchers.

The seven patients were born between 1933 and 1949, and ranged from 46 to 62 years old at the time of disease onset. Based on all their data, the researchers determined that the minimum estimated incubation period ranged from 34-41 years. The incubation period in men who only took part in the funeral feasts when very young may have been 39-56 years or even 63 years, according to the investigators.

Eight of the 10 patients for whom genetic data were available were heterozygous for a polymorphism associated with extended incubation periods and resistance to prion diseases.

These findings suggest that an epidemic of variant CJD could show up many years from now, parallel with the aging of people who consumed beef from cows with bovine spongiform encephalopathy (BSE) back in the 1990s. The results were published in the June 24 issue of The Lancet.



Related Links:
University College, London
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.